Rapid, specific, and sensitive measurements of plasma sphingomyelin and phosphatidylcholine

被引:95
作者
Hojjati, MR [1 ]
Jiang, XC [1 ]
机构
[1] Suny Downstate Med Ctr, Dept Anat & Cell Biol, Brooklyn, NY 11203 USA
关键词
phospholipid measurement; large-scale and high-throughput assays; enzymatic measurements;
D O I
10.1194/jlr.D500040-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sphingomyelin (SM) and phosphatidylcholine (PC) are two major phospholipids on plasma lipoproteins. Their concentration is classically measured by lipid extraction, thin-layer chromatography, and phosphate determination on separated SM or PC spots. Here, we describe two rapid, specific, and sensitive enzymatic measurements for both phospholipids. Plasma was incubated with bacterial sphingomyelinase ( for SM measurement) or bacterial PC-specific phospholipase D (for PC measurement), alkaline phosphatase, choline oxidase, peroxidase, N-ethyl-N-(2-hydroxy-3-sulfopropyl)-3,5- dimethoxyaniline, and 4-aminoantipyrine for 45 min. A blue dye, with an optimal absorption at 595 nm, was generated. PC levels did not influence SM measurement and vice versa. The linear range for the SM measurement was 0.5-5 mu g, and that for PC was 2.5-20 mu g. The mean percentage recovery was 98.0 +/- 5.2% for SM and 96.6 +/- 3.8% for PC. The interassay coefficient of variation of the assay was 1.7 +/- 0.05% for SM and 3.1 +/- 0.13% for PC. These two new methods are amenable to automation and can be adapted for large-scale, high-throughput assays.
引用
收藏
页码:673 / 676
页数:4
相关论文
共 14 条
[1]  
BARTLETT GR, 1959, J BIOL CHEM, V234, P466
[2]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[3]   Development of the lipid-rich core in human atherosclerosis [J].
Guyton, JR ;
Klemp, KF .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (01) :4-11
[4]   LIPOPROTEINS CONTAINING APO-B EXTRACTED FROM HUMAN AORTAS - STRUCTURE AND FUNCTION [J].
HOFF, HF ;
MORTON, RE .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1985, 454 :183-194
[5]   Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice [J].
Hojjati, MR ;
Li, ZQ ;
Zhou, HW ;
Tang, SS ;
Huan, CM ;
Ooi, E ;
Lu, SD ;
Jiang, XC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (11) :10284-10289
[6]   Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase [J].
Jeong, TS ;
Schissel, SL ;
Tabas, I ;
Pownall, HJ ;
Tall, AR ;
Jiang, XC .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (04) :905-912
[7]   Plasma sphingomyelin level as a risk factor for coronary artery disease [J].
Jiang, XC ;
Paultre, F ;
Pearson, TA ;
Reed, RG ;
Francis, CK ;
Lin, M ;
Berglund, L ;
Tall, AR .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (12) :2614-2618
[8]   Changes in the phospholipid composition of the arterial cell can result in severe atherosclerotic lesions [J].
Kummerow, FA ;
Cook, LS ;
Wasowicz, E ;
Jelen, H .
JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2001, 12 (10) :602-607
[9]   Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice [J].
Park, TS ;
Panek, RL ;
Mueller, SB ;
Hanselman, JC ;
Rosebury, WS ;
Robertson, AW ;
Kindt, EK ;
Homan, R ;
Karathanasis, SK ;
Rekhter, MD .
CIRCULATION, 2004, 110 (22) :3465-3471
[10]  
PHILLIPS GB, 1967, J LIPID RES, V8, P676